AWB(AI with BioTech) uses data from preclinical and clinical studies to model a drug’s effect on patients and predict whether it will be successful or not at treating a specific disease. The company has worked on a wide range of indications including liver disease, respiratory disease, hepatitis, im...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2020 (4 years) |
Funding status Series B |
Company type SME |